Zevra Therapeutics ZVRA
NASDAQ ZVRA
$12.40 -0.14 (-1.12%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zevra Therapeutics (ZVRA) Current Taxes (2025 - 2026)

Zevra Therapeutics' (ZVRA) quarterly Current Taxes came in at $20.4 million in Q1 2026, up 48.46% on a QoQ basis from $13.7 million in Q4 2025.

Analysis

Zevra Therapeutics (ZVRA) Current Taxes (2025 - 2026) Analysis & Trends

Zevra Therapeutics (ZVRA) has 2 years of Current Taxes data on file, last reported at $20.4 million in Q1 2026.

  • Quarterly Current Taxes changed N/A year-over-year to $20.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.4 million (changed N/A YoY) and the FY2025 annual result came in at $13.7 million, changed N/A from the prior year.
  • Current Taxes climbed to $20.4 million in Q1 2026, from $13.7 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $20.4 million in Q1 2026 to a low of $13.7 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 49.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 76.32 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Zevra Therapeutics 734.60 Mn 513.03 Mn 38.18 Mn 20.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.84 Mn
Mar 31, 2026 20.35 Mn
Dec 31, 2025 13.71 Mn